Links to 5 new Hepatitis C Articles

[Guest guest]

Vertex CEO Uses Stanley Stage To Needle Firm's Analyst

Wall Street Journal

He has been skeptical about whether Vertex's new hepatitis C drug, Incivek, will

meet high sales expectations from others on Wall Street. But Vertex shares are

up more than 40% year-to-date, trading recently at $50.21, buoyed by early signs

that ...

See all stories on this topic » Lawyer: Teva, Baxter Could Have Prevented Hep C

Outbreaks by Selling Smaller ...

Becker's ASC Review

By Fields | September 13, 2011 Hepatitis C outbreaks could have been

avoided if drug manufacturers Baxter Healthcare Services and Teva Parenteral

Medicine had sold smaller vials of propofol to healthcare facilities, argued a

patient's lawyer ...

See all stories on this topic »

Woman pleads not guilty to chemotherapy fraud charges at Mississippi clinic

Washington Post

Between 150 and 200 former patients have been tested for HIV and Hepatitis since

the clinic was shut down in July, and testing continues. Mississippi Department

of Health officials say none of the patients tested so far have been infected

with HIV or ...

See all stories on this topic »Genotyping hepatitis C patients improves

prediction of treatment response

EurekAlert (press release)

In this week's PLoS Medicine, Booth of the University of Sydney, Australia

and colleagues show that genotyping hepatitis C patients for the IL28B, HLA-C

and KIR genes substantially improves doctors' ability to predict whether or not

patients will ...

See all stories on this topic »Hepatitis C vaccine a step closer

Courier Mail

VACCINE POSSIBILITY: University of New South Wales' Professor Lloyd led a

study into weaknesses in the hepatitis C virus that could lead to an effective

vaccine. Picture: Sam Mooy Source: The Daily Telegraph AUSTRALIAN researchers

have ...

See all stories on this topic »

[Guest guest]

Vertex CEO Uses Stanley Stage To Needle Firm's Analyst

Wall Street Journal

He has been skeptical about whether Vertex's new hepatitis C drug, Incivek, will

meet high sales expectations from others on Wall Street. But Vertex shares are

up more than 40% year-to-date, trading recently at $50.21, buoyed by early signs

that ...

See all stories on this topic » Lawyer: Teva, Baxter Could Have Prevented Hep C

Outbreaks by Selling Smaller ...

Becker's ASC Review

By Fields | September 13, 2011 Hepatitis C outbreaks could have been

avoided if drug manufacturers Baxter Healthcare Services and Teva Parenteral

Medicine had sold smaller vials of propofol to healthcare facilities, argued a

patient's lawyer ...

See all stories on this topic »

Woman pleads not guilty to chemotherapy fraud charges at Mississippi clinic

Washington Post

Between 150 and 200 former patients have been tested for HIV and Hepatitis since

the clinic was shut down in July, and testing continues. Mississippi Department

of Health officials say none of the patients tested so far have been infected

with HIV or ...

See all stories on this topic »Genotyping hepatitis C patients improves

prediction of treatment response

EurekAlert (press release)

In this week's PLoS Medicine, Booth of the University of Sydney, Australia

and colleagues show that genotyping hepatitis C patients for the IL28B, HLA-C

and KIR genes substantially improves doctors' ability to predict whether or not

patients will ...

See all stories on this topic »Hepatitis C vaccine a step closer

Courier Mail

VACCINE POSSIBILITY: University of New South Wales' Professor Lloyd led a

study into weaknesses in the hepatitis C virus that could lead to an effective

vaccine. Picture: Sam Mooy Source: The Daily Telegraph AUSTRALIAN researchers

have ...

See all stories on this topic »